Beta Drugs Limited

Founded in 2005 and headquartered in Himachal Pradesh, India.

2005 | Solan, Himachal Pradesh (India) | Active
Last Updated:

Beta Drugs Profile

Key Indicators

  • Authorised Capital ₹ 11.00 Cr
  • Paid Up Capital ₹ 10.09 Cr
  • Company Age 19 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 29.94 Cr
  • Satisfied Charges ₹ 22.90 Cr
  • Revenue Growth 25.44%
  • Profit Growth 16.58%
  • Ebitda 7.77%
  • Net Worth 20.52%
  • Total Assets 27.17%

About Beta Drugs

Beta Drugs Limited (BDL) is a leading Public Limited Indian Non-Government Company incorporated in India on 21 September 2005 and has a history of 19 years and seven months. Its registered office is in Solan, Himachal Pradesh, India.

It is listed on the National Stock Exchange(NSE) under the ticker symbol BETA.

The Corporate was formerly known as Beta Drugs Private Limited. The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 11.00 Cr and a paid-up capital of Rs 10.09 Cr.

The company currently has active open charges totaling ₹29.94 Cr. The company has closed loans amounting to ₹22.90 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Beta Drugs Limited India are Nipun Arora as CFO and Rajni Charaya as Company Secretary. Balwant Singh, Sanjay Sehgal, Varun Batra, and Seven other members serve as directors at the Company.

Company Details

  • Location

    Solan, Himachal Pradesh, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24230HP2005PLC028969

  • Company No.

    028969

  • Stock Symbol

    NSE : BETA

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    21 Sep 2005

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Himachal Pradesh

Industry

Pharma
Company report

Beta Drugs Limited

Explore comprehensive data for Beta Drugs Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Beta Drugs?

Executive Team (4)

NameDesignationAppointment DateStatus
Varun Batra Country flag representing In Managing Director01-Aug-2014Current
Rahul Batra Country flag representing In Managing Director01-Aug-2014Current
Nipun Arora CFO05-Mar-2021Current
Rajni Charaya Country flag representing In Company Secretary17-Jul-2017Current

Board Members (8)

NameDesignationAppointment DateStatus
Manmohan Khanna Country flag representing In Director 26-Jul-2017Current
Ajay Mahipal Country flag representing In Director 27-Nov-2024Current
Balwant Singh Country flag representing In Whole-Time Director 01-Aug-2014Current
Sanjay Sehgal Country flag representing In Director 27-Nov-2024Current
Monica Jain Country flag representing In Director 05-Feb-2025Current
Rohit Parti Country flag representing In Director 26-Jul-2017Current

Financial Performance of Beta Drugs.

Beta Drugs Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 25.44% increase. The company also saw a substantial improvement in profitability, with a 16.58% increase in profit. The company's net worth Soared by an impressive increase of 20.52%.

Beta Drugs revenue growth over time
Beta Drugs profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
25.44%
Revenue from Operations
25.18%
Total Assets
27.17%
Profit or Loss
16.58%
Net Worth
20.52%
EBITDA
7.77%

What is the Ownership and Shareholding Structure of Beta Drugs?

In 2024, Beta Drugs had a promoter holding of 66.73% and a public holding of 33.25%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹29.94 Cr

Satisfied Charges

₹22.90 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 15.06 Cr
  • Uco Bank : 7.50 Cr
  • Sidbi : 4.50 Cr
  • Others : 2.18 Cr
  • Axis Bank Limited : 0.70 Cr

Latest Charge Details

DateLenderAmountStatus
29 Jul 2024Hdfc Bank Limited₹1.66 MOpen
18 Jul 2024Others₹1.05 CrOpen
02 Apr 2024Uco Bank₹7.50 CrOpen
27 Feb 2024Others₹1.70 MOpen
22 Feb 2024Sidbi₹1.60 CrOpen

How Many Employees Work at Beta Drugs?

Beta Drugs has a workforce of 382 employees as of Mar 31, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Beta Drugs Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Beta Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Beta Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Beta Drugs

Recent activity within the organization

  • Director Appointment

    Monica Jain was appointed as a Director was appointed as a Director on 05 Feb 2025 & has been associated with this company since 2 months 21 days .

  • Director Appointment

    Lalit Kumar Watts was appointed as a Director was appointed as a Director on 05 Feb 2025 & has been associated with this company since 2 months 21 days .

  • Director Appointment

    Sanjay Sehgal was appointed as a Director was appointed as a Director on 27 Nov 2024 & has been associated with this company since 4 months 30 days .

  • Director Appointment

    Ajay Mahipal was appointed as a Director was appointed as a Director on 27 Nov 2024 & has been associated with this company since 4 months 30 days .

  • Charges

    A charge registered on 04 Oct 2019 via Charge ID 100296298 with Others was fully satisfied on 05 Nov 2024.

  • Annual General Meeting

    Beta Drugs Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Beta Drugs Limited?

    Beta Drugs Limited was incorporated on 21 Sep 2005.

  • What is authorized share capital and paid-up capital of Beta Drugs Limited?

    The authorized share capital of Beta Drugs Limited is ₹ 11.00 Cr and paid-up capital is ₹ 10.09 Cr.

  • Who are the current board members & directors of Beta Drugs Limited?

    Currently 12 directors are associated with Beta Drugs Limited.

    • Balwant Singh
    • Sanjay Sehgal
    • Varun Batra
    • Rahul Batra
    • Monica Jain
    • Ajay Mahipal
    • Manmohan Khanna
    • Rohit Parti
    • Ashutosh Shukla
    • Lalit Kumar Watts
    • Nipun Arora
    • Rajni Charaya

  • What is the registered address of Beta Drugs Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Beta Drugs Limited is Village Nandpur India, Baddi, Himachal Pradesh, 174101.

  • What is the corporate identification number (CIN) and company number of Beta Drugs Limited?

    The corporate identification number (CIN) of Beta Drugs Limited is L24230HP2005PLC028969 and the company number is 028969 as per Ministry of Corporate Affairs (MCA).

  • Is Beta Drugs Limited registered with any stock exchange in India?

    Yes, Beta Drugs Limited is registered on National Stock Exchange (NSE).

  • What is the official website of Beta Drugs Limited?

    The Official website of Beta Drugs Limited is https://www.betadrugslimited.com

  • What has been the recent revenue trend for Beta Drugs Limited?

    According to the financial reports for the fiscal year 2024, the revenue trend for Beta Drugs Limited has risen by 25.44%.

  • How many employees does Beta Drugs Limited currently have?

    As Per 2024 financial reports, 382 employees are currently employed by Beta Drugs Limited.

  • What change has been observed in the net worth of Beta Drugs Limited, and by what percentage?

    The financial reports for the fiscal year 2024 indicates that The net worth of Beta Drugs Limited has experienced an upsurge of 20.52%.

  • What are the total open charges for Beta Drugs Limited?

    As per the financial statements for fiscal Year 2024, The total open charges for Beta Drugs Limited amount to ₹ 29.94 Cr.

  • When was the last Balance Sheet of Beta Drugs Limited filed with the ROC?

    The most recent Balance Sheet for Beta Drugs Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development